| scholarly article | Q13442814 |
| P50 | author | J. Keith Joung | Q28033740 |
| Kendell Clement | Q56548714 | ||
| P2093 | author name string | Jing Zeng | |
| Daniel E Bauer | |||
| Yuxuan Wu | |||
| Luca Pinello | |||
| Jason M Gehrke | |||
| Oliver Cervantes | |||
| P2860 | cites work | Therapeutic genome editing: prospects and challenges | Q28087380 |
| Genome editing. The new frontier of genome engineering with CRISPR-Cas9 | Q28252298 | ||
| A DNA sequence recognition loop on APOBEC3A controls substrate specificity | Q28538801 | ||
| CRISPR-Cas systems for editing, regulating and targeting genomes | Q29615781 | ||
| Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases | Q33593394 | ||
| Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity | Q33630551 | ||
| Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. | Q33786397 | ||
| In vivo genome editing using Staphylococcus aureus Cas9 | Q34043628 | ||
| Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage | Q34046684 | ||
| GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases | Q34454104 | ||
| High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Q34507554 | ||
| Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. | Q36178493 | ||
| The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization | Q36921174 | ||
| The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution. | Q37265843 | ||
| Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia | Q37281429 | ||
| Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B. | Q37629738 | ||
| Beta-thalassemia. | Q37680651 | ||
| Genome-wide target specificities of CRISPR RNA-guided programmable deaminases | Q38842681 | ||
| AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity | Q40818553 | ||
| Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. | Q41562658 | ||
| Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions | Q41960134 | ||
| Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor | Q42071921 | ||
| Analyzing CRISPR genome-editing experiments with CRISPResso | Q42551389 | ||
| Correction of β-thalassemia mutant by base editor in human embryos | Q46124667 | ||
| Rescue of high-specificity Cas9 variants using sgRNAs with matched 5' nucleotides | Q46148608 | ||
| Enhanced proofreading governs CRISPR-Cas9 targeting accuracy | Q46347859 | ||
| Three new beta-globin gene promoter mutations identified through newborn screening | Q46736299 | ||
| Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage. | Q48230762 | ||
| Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion. | Q48357710 | ||
| Highly efficient RNA-guided base editing in mouse embryos. | Q50986337 | ||
| Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. | Q51215555 | ||
| Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. | Q52430644 | ||
| A novel promoter mutation (HBB: c.-75G>T) was identified as a cause of β(+)-thalassemia | Q86678985 | ||
| P433 | issue | 10 | |
| P921 | main subject | Cas9 | Q16965677 |
| P304 | page(s) | 977-982 | |
| P577 | publication date | 2018-07-30 | |
| P1433 | published in | Nature Biotechnology | Q1893837 |
| P1476 | title | An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities | |
| P478 | volume | 36 |
| Q61444306 | A panel of eGFP reporters for single base editing by APOBEC-Cas9 editosome complexes |
| Q92717013 | A transient reporter for editing enrichment (TREE) in human cells |
| Q94938632 | Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing |
| Q60927165 | BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B |
| Q101344092 | Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines |
| Q57060018 | Base editing a CRISPR way |
| Q94563192 | Base editing goes into hyperdrive |
| Q92142962 | Base editing the mammalian genome |
| Q100737258 | Base editing: advances and therapeutic opportunities |
| Q57464865 | Base editing: precision chemistry on the genome and transcriptome of living cells |
| Q58120494 | Blossom of CRISPR technologies and applications in disease treatment |
| Q97636550 | CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells |
| Q93065070 | CRISPR DNA base editors with reduced RNA off-target and self-editing activities |
| Q98513556 | CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs |
| Q90833369 | CRISPR RNA-guided autonomous delivery of Cas9 |
| Q98564443 | CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets |
| Q92136735 | Challenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants |
| Q72828038 | Comparison of cytosine base editors and development of the BEable-GPS database for targeting pathogenic SNVs |
| Q90384557 | Computer simulations explain mutation-induced effects on the DNA editing by adenine base editors |
| Q92093452 | Continuous evolution of base editors with expanded target compatibility and improved activity |
| Q98231784 | Current Status and Challenges of DNA Base Editing Tools |
| Q66987742 | Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos |
| Q91692625 | Dead Cas Systems: Types, Principles, and Applications |
| Q64894430 | Delivering on the promise of gene editing for cystic fibrosis. |
| Q99724691 | Delivery Approaches for Therapeutic Genome Editing and Challenges |
| Q102141439 | Docking sites inside Cas9 for adenine base editing diversification and RNA off-target elimination |
| Q96127696 | Dual base editor catalyzes both cytosine and adenine base conversions in human cells |
| Q57059857 | Efficient C-to-T base editing in plants using a fusion of nCas9 and human APOBEC3A |
| Q60301059 | Efficient RNA-guided base editing for disease modeling in pigs |
| Q64914639 | Efficient and precise base editing in rabbits using human APOBEC3A-nCas9 fusions. |
| Q93116004 | Efficient base editing for multiple genes and loci in pigs using base editors |
| Q92782304 | Efficient base editing with high precision in rabbits using YFE-BE4max |
| Q61124564 | Engineering of high-precision base editors for site-specific single nucleotide replacement |
| Q89637844 | Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors |
| Q92534404 | Expanding C-T base editing toolkit with diversified cytidine deaminases |
| Q64067554 | Expanding the CRISPR Toolbox in Zebrafish for Studying Development and Disease |
| Q89474582 | Expanding the genome-targeting scope and the site selectivity of high-precision base editors |
| Q92755908 | Genome Editing in Agriculture: Technical and Practical Considerations |
| Q91901314 | Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9 |
| Q96641394 | Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors |
| Q98463768 | Genome-wide specificity of dCpf1 cytidine base editors |
| Q91330218 | In situ readout of DNA barcodes and single base edits facilitated by in vitro transcription |
| Q64056410 | In vivo continuous evolution of metabolic pathways for chemical production |
| Q64247269 | Increasing Cytosine Base Editing Scope and Efficiency With Engineered Cas9-PmCDA1 Fusions and the Modified sgRNA in Rice |
| Q94563242 | Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain |
| Q91928931 | Inference of single-cell phylogenies from lineage tracing data using Cassiopeia |
| Q89864978 | MagnEdit-interacting factors that recruit DNA-editing enzymes to single base targets |
| Q92730750 | Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox |
| Q64094107 | New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes |
| Q66988056 | Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis |
| Q99635760 | Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions |
| Q96816762 | Precise, predictable multi-nucleotide deletions in rice and wheat using APOBEC-Cas9 |
| Q64086708 | Programmable Base Editing of the Sheep Genome Revealed No Genome-Wide Off-Target Mutations |
| Q56889180 | Protein Engineering Strategies to Expand CRISPR-Cas9 Applications |
| Q100559472 | RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code |
| Q90109113 | RNA-guided retargeting of Sleeping Beauty transposition in human cells |
| Q92662384 | Rewriting Human History and Empowering Indigenous Communities with Genome Editing Tools |
| Q100437380 | Robustly improved base editing efficiency of Cpf1 base editor using optimized cytidine deaminases |
| Q97424577 | Sequence-specific prediction of the efficiencies of adenine and cytosine base editors |
| Q90736777 | Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing |
| Q91522635 | Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells |
| Q59129098 | Targeting fidelity of adenine and cytosine base editors in mouse embryos |
| Q91451483 | Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing |
| Q98779241 | The Development and Application of a Base Editor in Biomedicine |
| Q91904611 | The emerging and uncultivated potential of CRISPR technology in plant science |
| Q92419599 | The next generation of CRISPR-Cas technologies and applications |
| Q91875200 | Therapeutic base editing of human hematopoietic stem cells |
| Q91861384 | Towards quantitative and multiplexed in vivo functional cancer genomics |
Search more.